🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,413 results for “ACE” Clear

  1. GTX-104

    Grace Therapeutics

    Aneurysmal Subarachnoid Hemorrhage

    phase 1 small molecule completed

    1 trial

  2. Gemtuzumab Ozogamicin

    Jazz Pharmaceuticals Ireland Limited

    Acute Myelogenous Leukemia

    phase 1 small molecule terminated

    1 trial

  3. Gilteritinib

    Jazz Pharmaceuticals Ireland Limited

    Acute Myeloid Leukemia With FLT3/ITD Mutation

    phase 1 small molecule active

    1 trial

  4. HBT-708

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Solid Tumors

    phase 1 small molecule active

    1 trial

  5. HEC 68498

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Idiopathic Pulmonary Fibrosis

    phase 1 small molecule completed

    1 trial

  6. HEC-007 injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Subjects

    phase 1 small molecule active

    1 trial

  7. HEC-151 Injection

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy Adult Male

    phase 1 small molecule active

    1 trial

  8. HEC113995

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Major Depressive Disorder

    phase 1 small molecule completed

    1 trial

  9. HEC113995 PA•H2O tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Major Depressive Disorder

    phase 1 small molecule completed

    1 trial

  10. HEC113995PA•H2O tablet

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  11. HEC116094

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Influenza

    phase 1 small molecule completed

    1 trial

  12. HEC122505MsOH

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Parkinson Disease

    phase 1 small molecule completed

    1 trial

  13. HEC169584 capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Non - Alcoholic Steatohepatitis

    phase 1 small molecule active

    1 trial

  14. HEC30654AcOH capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  15. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Kidney Diseases

    phase 1 small molecule completed

    1 trial

  16. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Healthy

    phase 1 small molecule completed

    1 trial

  17. HEC53856

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Hemodialysis

    phase 1 small molecule completed

    1 trial

  18. HEC68498

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Advanced Refractory Solid Tumors

    phase 1 small molecule completed

    1 trial

  19. HEC73077 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Diabetic Nephropathy

    phase 1 small molecule completed

    1 trial

  20. HEC74647

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    1 trial

  21. HEC74647PA capsule

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Chronic Hepatitis C

    phase 1 small molecule completed

    2 trials

  22. HEC83518

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Insomnia

    phase 1 small molecule completed

    1 trial

  23. HEC83518 tablets

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Insomnia

    phase 1 small molecule completed

    1 trial

  24. HEC89736

    Sunshine Guojian Pharmaceutical (Shanghai) Co.,

    Relapsed or Refractory B-cell Hematologic Malignancies

    phase 1 small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources